Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...

As previously reported, BofA downgraded Integer (ITGR) to Neutral from Buy with a price target of $87, down from $135. The company’s 2026 guidance cut is “a reminder that visibility is not as clear as ...

Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.31 in the first quarter of 2025, which improved 14.9% year over year. The figure topped the Zacks Consensus Estimate ...

Integer programming and combinatorial optimization form the backbone of many decision-making and resource allocation problems across diverse fields, from logistics and telecommunications to finance ...